Metastatic spread and "escape" from the immune defenses of the host
- PMID: 1025472
Metastatic spread and "escape" from the immune defenses of the host
Abstract
The effectiveness of the host's immune reaction against primary and disseminated tumors depends not only on the magnitude of the host's immune response, such as the number of cytotoxic cells and antibody molecules produced, but also on the capacity of tumor cells to evade destruction. The latter process which has been termed "escape" depends on several factors including intrinsic properties of the tumor cell. In some experimental systems, it was shown that the capacity of disseminated tumor cells to give rise to distant metastases is in part determined by the efficiency of escape. Tumors which in vivo appear to be nonimmunogenic may still carry tumor-specific antigens to which the host responds by making cytotoxic mononuclear cells, but these fail to kill because escape is effective.
Similar articles
-
Effects on tumor growth in vivo by manipulation of the tumor immune response.Johns Hopkins Med J Suppl. 1974;3:51-60. Johns Hopkins Med J Suppl. 1974. PMID: 4370816 No abstract available.
-
Nutrition and tumor immunity: divergent effects of antitumor antibody.Cancer Res. 1975 Nov;35(11 Pt. 2):3317-9. Cancer Res. 1975. PMID: 1104143 Review.
-
Immune rejection of tumor cells: in vivo significance of anti-tumor in vitro immune reactions.Biomedicine. 1975 Jul;22(4):249-54. Biomedicine. 1975. PMID: 776239 Review.
-
Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.Cancer Res. 1991 Dec 1;51(23 Pt 1):6372-80. Cancer Res. 1991. PMID: 1933900
-
[Immunodepressive action of the tumor].Vopr Onkol. 1978;24(3):99-106. Vopr Onkol. 1978. PMID: 347712 Review. Russian. No abstract available.
Cited by
-
Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005.Int J Colorectal Dis. 2007 Jul;22(7):727-36. doi: 10.1007/s00384-006-0245-z. Epub 2006 Dec 5. Int J Colorectal Dis. 2007. PMID: 17146588 Review.
-
Host immunity to mycoplasma antigens introduced into B16 melanoma cells: effect on tumor growth rate and metastasis.Clin Exp Metastasis. 1988 Jul-Aug;6(4):271-84. doi: 10.1007/BF01753574. Clin Exp Metastasis. 1988. PMID: 3129225